共 50 条
- [36] Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3+anti-PD-1-based immunotherapies ONCOIMMUNOLOGY, 2023, 12 (01):
- [39] Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy Journal of Hematology & Oncology, 16
- [40] Clinical Significance and Prognostic Value of the Expression of LAG-3 and FGL1 in Esophageal Squamous Cell Carcinoma Bulletin of Experimental Biology and Medicine, 2023, 174 : 774 - 778